Cytiva Denmark ApS: Financial statements 2024
CVR: 43126261
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Cytiva Denmark ApS (CVR 43126261) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 1,747,415,444 and a net result of DKK 80,542,305 compared with DKK 66,254,250 the year before. The profit margin was 4.6%. Equity in the 2024 report amounted to DKK 269,264,917. The solvency ratio was 46.9%.
- Revenue
- DKK 1,747,415,444
- Gross Profit
- DKK 129,304,662
- Profit/Loss
- DKK 80,542,305
- Equity
- DKK 269,264,917
- Total Assets
- DKK 574,401,982
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 1.7B | 129.3M | 80.5M | 269.3M | 0 |
| 2023 | - | 101.1M | 66.3M | 188.7M | 23 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Cytiva Denmark ApS has published its annual report for 2023. Gross profit came to DKK 101,050,505, and the net result was DKK 66,254,250.
About Cytiva Denmark ApS
Cytiva Denmark ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nicolaj Peter Saxild, Nils Tomas Ljunggren and Per Jonas Jakstad. The company is owned by Pall Norden AB. The company has 26 employees (2026). In 2025, the company reported revenue of DKK 1,718,386,073 and a net result of DKK 67,011,190 compared with DKK 80,542,305 the year before. Equity in the 2025 report amounted to DKK 146,276,107.